Brittany Lord, Ph.D., M.P.H., M.S., joined the Integrative Tumor Epidemiology Branch (ITEB) as a postdoctoral Cancer Prevention Fellow in 2020. Dr. Lord earned her Ph.D. in genetics from the University of Georgia, Athens, in 2019. Working with Dr. Melissa B. Davis, her doctoral research focused on breast cancer disparities in women of African ancestry. She focused on defining the role of the atypical chemokine receptor (ACKR1/DARC) gene in modifying tumor immunogenicity during breast tumorigenesis. She earned her M.S. in biotechnology from Claflin University, South Carolina, in 2014 and her M.P.H. from Johns Hopkins University, Baltimore, Maryland, with a concentration in epidemiology and biostatistics in 2020. In 2021, Dr. Lord received a Scholar-in-Training Award from the American Association for Cancer Research. In 2022, her proposal was selected for an NCI FLEX Award and she received the NCI Cancer Prevention Fellowship Program Merit Award, which recognizes trainees with the ability to rise to the highest level of science, leadership, and service.
Dr. Lord’s research interests include understanding breast cancer disparities and the contribution of genetic ancestry to disease risk and reoccurrence, in addition to investigating epidemiologic risk factors for breast cancer in diverse populations. In ITEB, Dr. Lord works under the mentorship of Gretchen Gierach, Ph.D., M.P.H., Chief, and senior investigator, to assess epidemiologic and epigenetic risk factors for breast cancer, focusing on women of African ancestry.